Skip to main content
. 2020 Jul 21;11(29):2834–2846. doi: 10.18632/oncotarget.27670

Table 2. Prognostic factors for cancer-specific survival in all patients with ESCC.

Variables Patients (n = 191) Category or characteristics Univariate analyses Multivariate analyses
HR 95% CI p value HR 95% CI p value
Gender 22/169 (female/male) 1.310 0.599–2.867 0.4993
Age 81/110 (<65 / ≥65) 0.961 0.594–1.554 0.8713
BMI 144/47 (≥18.5 / <18.5) 1.616 0.946–2.758 0.0787
Alb 159/32 (≥3.5 / <3.5) 2.747 1.557–4.845 0.0005 2.498 1.333–4.684 0.0043
CRP 148/43 (<0.5 / ≥0.5) 2.262 1.344–3.807 0.0021 1.205 0.673–2.157 0.5300
GNRI 110/81 (≥97.1 / <97.1) 2.879 1.764–4.698 < 0.0001 1.941 1.120–3.365 0.0181
Tumor size 54/136 (<3 / ≥3) 2.704 1.415–5.170 0.0026 1.229 0.614–2.461 0.5600
pTNM stage 114/77 (I, II / III) 4.600 2.747–7.704 < 0.0001 3.884 2.229–6.769 < 0.0001
Differentiation 64/127 (well / other) 1.908 1.074–3.390 0.0276 2.307 1.262–4.220 0.0066
SCC 139/52 (<1.5 / ≥1.5) 1.546 0.921–2.595 0.0990